Key Metrics
CiteScore 

18.9
Impact Factor 

10 - 15
SNIP 

3.53
Recommended pre-submission checks
Powered by 

JACC: Heart Failure Journal Specifications
Indexed in the following public directories
Web of Science
SJR
| Overview | |
| Publisher | ELSEVIER SCI LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2013 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in JACC: Heart Failure ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in JACC: Heart Failure
Impact of Transcatheter Tricuspid Valve Replacement on Liver and Kidney Function in a Real-World Population.
- 20 May 2026
- JACC. Heart failure
Impact of Donor Left Ventricular Geometric Remodeling and Hypertrophy on Heart Acceptance and Recipient Survival.
- 19 May 2026
- JACC. Heart failure
Insurance Type Is Associated With Management and Outcomes in Young Adults Hospitalized With Heart Failure.
- 19 May 2026
- JACC. Heart failure
Enabling a Renin-Angiotensin System Inhibitor and/or a Mineralocorticoid Receptor Antagonist in Patients With Heart Failure and/or Chronic Kidney Disease: Unintended Consequences of Increased Sodium Exposure.
- 18 May 2026
- JACC. Heart failure
Geographic Variation in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: Insights From the FINEARTS-HF Trial.
- 15 May 2026
- JACC. Heart failure
Forty Years of Heart Failure Drug Clinical Trials: Have We Made Progress on Enrollment?
- 15 May 2026
- JACC. Heart failure
Impact of Transcatheter Tricuspid Valve Replacement on Liver and Kidney Function in a Real-World Population.
- 20 May 2026
- JACC. Heart failure
Impact of Donor Left Ventricular Geometric Remodeling and Hypertrophy on Heart Acceptance and Recipient Survival.
- 19 May 2026
- JACC. Heart failure
Insurance Type Is Associated With Management and Outcomes in Young Adults Hospitalized With Heart Failure.
- 19 May 2026
- JACC. Heart failure
Enabling a Renin-Angiotensin System Inhibitor and/or a Mineralocorticoid Receptor Antagonist in Patients With Heart Failure and/or Chronic Kidney Disease: Unintended Consequences of Increased Sodium Exposure.
- 18 May 2026
- JACC. Heart failure
Geographic Variation in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: Insights From the FINEARTS-HF Trial.
- 15 May 2026
- JACC. Heart failure
Forty Years of Heart Failure Drug Clinical Trials: Have We Made Progress on Enrollment?
- 15 May 2026
- JACC. Heart failure